Clinical Trials Browser

Phase 3 × Interventional × Squamous NSCLC × Clear all

NCT03629925 2023-02-28

Sintilimab in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Therapy for Advanced or Metastatic Squamous NSCLC

Phase 3 Completed

357 enrolled 14 charts

Squamous NSCLC